Cobolimab Biosimilar HDBS0008: Expanding Access to TIM-3 Immune Checkpoint Inhibition Cobolimab is an investigational monoclonal antibody targeting T-cell immunoglobulin an … read more 25th Nov 2024 Shanza Riaz
Atezolizumab Biosimilar HDBS0009: Enhancing Access to PD-L1 Immunotherapy Atezolizumab (Tecentriq) is a monoclonal antibody targeting programmed death-ligand 1 … read more 25th Nov 2024 Shanza Riaz
MHC Class I vs MHC Class II: Key Differences and Functions Major Histocompatibility Complex (MHC) molecules are essential for immune recognition … read more 22nd Nov 2024 Shanza Riaz
